Registration - Consultant Lobbyist
The Canadian Forum for Rare Disease Innovators (RAREi) / Gerry Jeffcott, Consultant Lobbyist
Registration Information
Lobbyist name: Gerry Jeffcott, Consultant Lobbyist
Initial registration start date: 2026-03-04
Registration status: Active
Projected end date: No date provided
Registration number: 11976-6452
Associated Lobbying Activity Reports
Total number of Lobbying Activity Reports: 0
Lobbying Activity Reports - last 6 months: 0
Version 1 of 1 (2026-03-04 to present)
Version 1 of 1 (2026-03-04 to present)
Lobbying Information
Details Regarding the Identified Subject Matter |
|||||||
| Will the consultant lobbyist be arranging meetings between a public office holder and the client for the purpose of attempting to influence any of the matters listed: | Yes | ||||||
|
|||||||
BC Ministries/Provincial Entities
- Health
- Office of the Premier
Contingency Information
- Payment to the consultant lobbyist by the client, in whole or in part, is not contingent on the outcome of this lobbying activity.
- Payment to the consultant lobbyist by the client, in whole or in part, is not contingent on the success in arranging a meeting with public office holders on behalf of the client.
Client Details
Client Contact Information
The Canadian Forum for Rare Disease Innovators (RAREi)
Address:
PO Box 81062
Ottawa, ON K1P 1B1
Canada
Website:
rarei.ca
Description of Business Activities
RAREi is an informal coalition of 17 Canadian biopharmaceutical companies committed to improving the lives of rare disease patients by researching, developing, and commercializing rare disease treatments. It is committed to monitoring, responding to and shaping policy issues in the Canadian rare disease environment
Contributors to the Lobbying Activity
No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of the organization that has a direct interest in the outcome of the lobbying activity.
Government Funding in the Last 12 Months
No government funding was received within the preceding 12 months based on the submission date requirements for this registration.Other Entities (working together for the purposes of lobbying) Information
- Alexion Pharma Canada Corp.
-
1004 Middlegate Road Suite 5000
Mississauga, ON L4Y 1M4
Canada
-
1004 Middlegate Road Suite 5000
- Amgen Canada Inc. ON
-
6775 Financial Drive Suite 300
Mississauga, ON L5N 0A4
Canada
-
6775 Financial Drive Suite 300
- Amicus Therapeutics Canada Inc. , QC
-
6500 Trans-Canada Road, 4th Floor
Pointe Claire, QC H9R 0A5
Canada
-
6500 Trans-Canada Road, 4th Floor
- argenyx Canada
-
9131 Keele Street, Suite A4
Vaughan, ON L4K 0G7
Canada
-
9131 Keele Street, Suite A4
- Biogen Canada
-
3300 Bloor St West, Suite 1200
Toronto, ON M8X 2X2
Canada
-
3300 Bloor St West, Suite 1200
- Biomarin Pharmaceuticals Inc. (c/o Mark Bennett, Cassels Brock)
-
40 KING STREET,
2100 SCOTIA PLAZA
Toronto, ON M5H 3C2
Canada
-
40 KING STREET,
- Ipsen Pharmaceuticals Canada Inc.
-
5060 Spectrum Way, 5th Floor
Mississauga, ON L4W 5N5
Canada
-
5060 Spectrum Way, 5th Floor
- Johnson & Johnson Innovative Medicine
-
19 Green Belt Dr.
Toronto, ON M3C 1L9
Canada
-
19 Green Belt Dr.
- Medison Pharma Canada Inc.
-
154 University Avenue, Suite 400
Toronto,, ON M5H 3Y9
Canada
-
154 University Avenue, Suite 400
- PTC Therapeutics Canada ULC
-
1100 Burloak Drive, Suite 300
Burlington, ON L7L 6B2
Canada
-
1100 Burloak Drive, Suite 300
- Recordati Rare Disease Canada Inc. , ON
-
3080 Yonge Street Suite 6060
Toronto, ON M4N 3N1
Canada
-
3080 Yonge Street Suite 6060
- Sanofi Canada Inc., ON
-
1755 Steeles Ave West
Toronto, ON M2R 3T4
Canada
-
1755 Steeles Ave West
- Sobi Canada Inc.
-
1155 North Service Road West
Unit #11
Oakville, ON L6M 3E3
Canada
-
1155 North Service Road West
- Tanabe Pharma Canada
-
100 King St West, Suite 5600
Toronto, ON M5X 1C9
Canada
-
100 King St West, Suite 5600
- UCB Canada Inc.
-
2201 Bristol Circle
Oakville, ON L6H 0J8
Canada
-
2201 Bristol Circle
- Ultragenyx Canada Inc.
-
550 Burrard Street, Suite 2900
Vancouver, BC V6C 0A3
Canada
-
550 Burrard Street, Suite 2900
- Vertex Pharmaceuticals (Canada) Inc.
-
20 Bay Street Suite 1520
Toronto, ON M5J 2N8
Canada
-
20 Bay Street Suite 1520
Affiliates with a Direct Interest in the Outcome
The Canadian Forum for Rare Disease Innovators (RAREi) does not have any affiliates that could have a direct interest in the outcome of the lobbying activities
Other Persons or Organizations with Direct Interests
The activities of The Canadian Forum for Rare Disease Innovators (RAREi) are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.
Lobbyist Details
Gerry Jeffcott | Has not held any “former public office holder” positions in BC, as defined in the Lobbyists Transparency Act
150 Metcalfe Street, Suite 604
Ottawa, ON K2P 1P1
Canada
Relevant Codes of Conduct
The consultant lobbyist does not have in place an undertaking to comply with any relevant codes of conduct.
Political, Sponsorship and Recall Contributions
| Consultant has lobbied, or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this client, on or after 2024-09-21: | Yes | |||||||||||||||
|
||||||||||||||||
Gifts or Benefits Provided to Public Officer Holders
No gifts or benefits were provided to public office holdersIndividuals Hired or Subcontracted to Lobbying on behalf of the Client
- Steve Vander Wal
Consultant Lobbyist Firm and Address
Firm: 3Sixty Public Affairs Inc.
150 Metcalfe Street, Suite 604
Ottawa, ON K2P 1P1
Canada
- Date Modified: